Brentuximab vedotin is a duly approved drug by US FDA and EU EMA. Adcetris is the brand name of this drug which is a research product of Seattle Genetics. This medication is indicated for the treatment of relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. The mechanism of action is that of antibody-drug conjugate, selectively targeting malignant cells. Adcetris in India is being imported through Named Patient licensing provisions. Takeda Pharmaceutical Company Limited has the manufacturing and distribution mandate in multiple global locations.
The first FDA approval for Brentuximab was granted in the year 2011, which was followed by EMA approval in 2012. They were accelerated approvals. These approvals were also specific to the indications of relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). Later in 2017 and 2018, the indications for Adcetris were expanded to cutaneous T-cell lymphoma (CTCL), classical Hodgkin lymphoma (cHL) and peripheral T-cell lymphoma (PTCL) with specific eligibility guidelines. Such grants have significantly accelerated the global relevance of this drug and the same is reflective of patients enquiring for Brentuximab in India.
Adcetris in India is one of the routine search trends from the major metro cities in the past couple of years. The enquiry pattern from various reputed Hospital networks further confirms its growing importance. Therefore it’s important for patients and even the medicinal fraternity to understand how this drug can be formally procured.
When you are diagnosed with a Haematological malignancy like Lymphoma, your treating physician would further investigate and determine the exact classification and stage of your disease. Right now Brentuximab is used for various indications that include newly diagnosed or previously untreated patients as well as patients who relapsed after previous treatment interventions.
Once your eligibility or candidature is confirmed by your Haematologist, you will be advised to procure Adcetris 50mg in India. You may be advised from two cycles up to six cycles. The dosage will be determined based on your body weight and other diagnostic outcomes.
You can look out for various options to source Adcetris in India after securing your Import Permit from CDSCO. It’s the authorized government body that issues import permits in the name of patient, after duly verifying the prescription and patient identity.
While you procure the legal permit for limited import, you can finalize your global supplier based on careful assessment. You must satisfy yourself on the credentials and prior experience of the suppliers you are engaging for the purpose of Brentuximab import.
Once you duly complete the necessary documentation for the sake of customs clearance at your preferred city, you can also advise for Adcetris home delivery or delivery to your Hospital pharmacy.
1. It is important for you to work with suppliers or global distributors with absolutely impeccable reputation. Many sources you come across after an online search of Adcetris in India may or may not be credible. Check for their office locations, referrals from Hospitals and even consultants to validate their claims.
2. Don’t make any payments without verifying the legal documents. You can ask for commercial invoices that can also be used for insurance claims or institutional reimbursements. Your supplier should also guide you well.
3. Do not fall prey to grey market stock which may not be effective medication as desired by your treating physicians. There are many fraudulent practices in the grey market.
Synergy Drugs has professionals who understand the sensitivities and intricacies of managing cold chain drug shipments like Brentuximab. You can take our help in reaching out to the right and reliable sources. You may rest assured when we provide with options for you to choose. We assist you in every step of your decision making.